TPWA
MLAB icon

Twin Peaks Wealth Advisors’s Mesa Laboratories MLAB Stock Holding History

Twin Peaks Wealth Advisors’s Portfolio MLAB Stock Details MLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1
Closed -$63 – 1344
2025
Q2 		$63 Buy
+1
New +$110 ﹤0.01% 2171

Other funds holding MLAB

CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
SCM
Simcoe Capital Management New York $576M AUM 36.22% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
KLP
Kent Lake PR Anasco, Puerto Rico $198M AUM 5.21% 1-Year Est. Return

Twin Peaks Wealth Advisors's MLAB Position: Q3 2025 in Review

Twin Peaks Wealth Advisors sold out of Mesa Laboratories (MLAB) in Q3 2025, closing a stake of 1 share — an estimated $63 sold.

Twin Peaks Wealth Advisors first reported a position in MLAB in Q2 2025 and held it in 1 quarter. The position peaked at $63 in Q2 2025. 141 funds tracked by Wall St. Rank hold MLAB as of Q3 2025.

  • Twin Peaks Wealth Advisors reported no remaining Mesa Laboratories position as of Q3 2025 after selling out during the quarter.
  • Twin Peaks Wealth Advisors sold 1 Mesa Laboratories share in Q3 2025, an estimated $63.
  • Twin Peaks Wealth Advisors first reported a position in Mesa Laboratories in Q2 2025 and held it in 1 quarter.
  • Twin Peaks Wealth Advisors's Mesa Laboratories position peaked at $63 in Q2 2025.
  • 141 funds tracked by Wall St. Rank held Mesa Laboratories as of Q3 2025.

Based on Twin Peaks Wealth Advisors's 13F filing for Q3 2025, filed 30 Oct 2025.